Organogenesis Holdings Inc.
Organogenesis Holdings Inc. (ORGO) Stock Overview
Explore Organogenesis Holdings Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
302.3M
P/E Ratio
8.14
EPS (TTM)
$0.15
ROE
0.10%
ORGO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Organogenesis Holdings Inc. (ORGO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 39.35, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.43.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 8.14 and a market capitalization of 302.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.